Prenoxdiazine

DB13397InvestigationalSmall molecule

Prenoxdiazine: Overview.

Chemical structure of Prenoxdiazine
Formula / weight
C23H27N3O · 361.489 g/mol (avg)

Resolves to

Compound
UNIIS491HH391HCAS47543-65-7ChEMBLCHEMBL2105302ChEBI135527
Clinical / RWD
ATCR05DB18
Structure
InChIKeyPXZDWASDNFWKSD-UHFFFAOYSA-NSMILESC(CC1=NC(CC(C2=CC=CC=C2)C2=CC=CC=C2)=NO1)N1CCCCC1

What you can answer from here — as of March 06, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 1 drug category
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Prenoxdiazine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In